It was reported that local IL-33 production could inhibit the tumor growth of a lymphoma cell line, by recruiting eosinophils into tumors through the overproduction of IL-5 from the IL-33-driven ILC2s [126]. This evidence concerns the gene IL33 and lymphoma.